about
Extraction of data for margin calculations in prostate radiotherapy from a commercial record and verify system.A pattern of early radiation-induced inflammatory cytokine expression is associated with lung toxicity in patients with non-small cell lung cancer.A prospective observational study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancerMagnetic resonance imaging for adaptive cobalt tomotherapy: A proposal.Effect of different breathing patterns in the same patient on stereotactic ablative body radiotherapy dosimetry for primary renal cell carcinoma: a case study.Geographic miss of lung tumours due to respiratory motion: a comparison of 3D vs 4D PET/CT defined target volumes.Radiation therapy quality assurance in clinical trials--Global Harmonisation GroupConsideration of the radiation dose delivered away from the treatment field to patients in radiotherapyA review of kidney motion under free, deep and forced-shallow breathing conditions: implications for stereotactic ablative body radiotherapy treatment.The use of dual vacuum stabilization device to reduce kidney motion for stereotactic radiotherapy planning.Stereotactic ablative body radiation therapy for primary kidney cancer: a 3-dimensional conformal technique associated with low rates of early toxicity.Brief histories of medical physics in Asia-Oceania.Long term OSLD reader stability in the ACDS level one auditMedical physics aspects of cancer care in the Asia Pacific region: 2014 survey results.'When measurements mean action' decision models for portal image review to eliminate systematic set-up errors.Image guidance and stabilization for stereotactic ablative body radiation therapy (SABR) treatment of primary kidney cancer.The Australian Clinical Dosimetry Service: a commentary on the first 18 monthsIntroduction of online adaptive radiotherapy for bladder cancer through a multicentre clinical trial (Trans-Tasman Radiation Oncology Group 10.01): Lessons learned.An analysis of respiratory induced kidney motion on four-dimensional computed tomography and its implications for stereotactic kidney radiotherapy.Survey of radiation oncology centres in Australia: report of the Radiation Oncology Treatment Quality Program.Successful implementation of image-guided radiation therapy quality assurance in the Trans Tasman Radiation Oncology Group 08.01 PROFIT Study.A contemporary review of stereotactic radiotherapy: inherent dosimetric complexities and the potential for detriment.The clinical significance and management of lesion motion due to respiration during PET/CT scanning.Australasian brachytherapy audit: results of the 'end-to-end' dosimetry pilot study.The outcome of a multi-centre feasibility study of online adaptive radiotherapy for muscle-invasive bladder cancer TROG 10.01 BOLART.Trans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework.The development of practice standards for radiation oncology in Australia: a tripartite approach.Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.Audit of radiation dose delivered in time-resolved four-dimensional computed tomography in a radiotherapy department.Ventilation/Perfusion Positron Emission Tomography--Based Assessment of Radiation Injury to Lung.Sparing healthy tissue and increasing tumor dose using bayesian modeling of geometric uncertainties for planning target volume personalization.Multimodality guidance for accurate bronchoscopic insertion of fiducial markers.Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy.Risk factors for radiotherapy incidents and impact of an online electronic reporting system.Differential (18)F-FDG and (18)F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung Cancer.In pursuit of individualised margins for prostate cancer patients undergoing image-guided radiotherapy: the effect of body mass index on intrafraction prostate motion.Comprehensive Australasian multicentre dosimetric intercomparison: issues, logistics and recommendations.Investigation of dose homogeneity for loose helical tomotherapy delivery in the context of breath-hold radiation therapy.Planning evaluation of radiotherapy for complex lung cancer cases using helical tomotherapy.Accuracy and Utility of Deformable Image Registration in (68)Ga 4D PET/CT Assessment of Pulmonary Perfusion Changes During and After Lung Radiation Therapy.
P50
Q33592549-32D6A9C8-8858-428A-9D35-FBE608F6A1A7Q34302308-8CA6F899-B062-459F-9B4F-9075B8D8D581Q34318535-91F56383-1C0A-4756-8E7F-229E18242B77Q34415525-70D28028-4963-4CFC-A701-E5CCBE18F4B4Q34666936-7CB44381-4AE6-465E-8E7A-B2E2144FA6F5Q34780782-BDE633EE-1892-4472-9639-D623BCAFD0EEQ34815954-25BCB958-151F-422C-96D4-C3C4B29BF2D9Q35059543-2846563E-4AD9-4F13-856E-E9256EAB623AQ35064379-EFFC8460-355B-4AA3-A408-8639A610C450Q35087413-C8358711-752A-4638-9A4B-D39DFAC4D486Q35466044-B7BEA77F-E2F5-472F-966B-5F80F6736E2FQ35609975-7D84F3CE-B397-42AF-80E2-598CF2CE1BDCQ35652006-4CDA9F02-28B4-4C28-AAEE-C28628115FDBQ35766022-D04621C3-6961-4D5C-AEA1-CF829B38F8AAQ35824772-4AC2A2A6-8A9C-48A0-9BB6-C51F5F97CC99Q35835259-F48B36FA-B224-4058-BF2C-66F98F52A24AQ36582096-FA9D72A7-6DE6-477F-A391-49D5A2716D8CQ36930974-12060EFD-B6CA-4C3F-B2CE-E38F5CFCB21EQ37312076-76F18774-549A-48F7-B786-67700BB68F82Q37583046-E3DCFE52-68DF-4A1E-8117-C2840C2FDD23Q37809194-B30ACA31-656A-4D23-AC0A-B61D8D0B0CF8Q37834640-CD2100E2-EE08-4EFC-8929-F1C5B67EAB3EQ37971475-D5AF6327-57DF-4AB7-8B09-B79470241FE4Q38122787-D02E99E4-27B0-4180-BC08-53FCD457B7DBQ38205612-65E66A34-8B42-4959-9215-F88731A5031EQ38262810-3F265AC6-8DAD-4AB7-BA3D-E0C9E8B09BD7Q38351141-FA706272-D770-4F89-A996-E97833D835A5Q38362240-473BCAB8-CA57-4F46-9EBB-DDD201B27F76Q38366457-C019C08A-2FDA-4D66-A745-838BFBB5145FQ38974148-73714E11-5942-4779-9B33-66E9556D25F7Q39021038-AD4E8489-F934-4E51-82DD-21922C3F365DQ39051062-DCE4FE50-CA79-41EA-BA7E-1A9A6897259CQ39135519-6553C146-D035-41DE-AE12-23ECC3FC3642Q39140750-204AA14A-379F-4004-8B11-B5E7461898E5Q39191502-1D678E8D-CD00-46E6-85B7-A486852400A8Q39775262-524E3F1A-10E3-4CD9-A814-FBAF9F74C18DQ39978388-28D4DF3E-BDA1-4D12-9BE2-A326334A5A02Q40424946-E4064C2A-A5E1-42CE-A8EA-FEED9EF3B35EQ40480064-E45D310A-63B8-495D-B0B2-1AA2572F974AQ40637550-E35E287F-F851-4C54-A14D-68ADB8776699
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tomas Kron
@ast
Tomas Kron
@en
Tomas Kron
@es
Tomas Kron
@nl
Tomas Kron
@sl
type
label
Tomas Kron
@ast
Tomas Kron
@en
Tomas Kron
@es
Tomas Kron
@nl
Tomas Kron
@sl
prefLabel
Tomas Kron
@ast
Tomas Kron
@en
Tomas Kron
@es
Tomas Kron
@nl
Tomas Kron
@sl
P106
P1153
26643569800
P21
P31
P496
0000-0002-5189-4046